Detecting clinically significant prostate cancer with a distributed parameter model based on quantitative dynamic contrast-enhanced magnetic resonance imaging
Hongjiang Zhang, Ji Du, Jiannan Lei, Kunhua Wu, Zujun Hou, Lei Lei, Bo Wang · 2026
Read Detecting clinically significant prostate cancer with a distributed parameter model based on quantitative dynamic contrast-enhanced magnetic resonance imaging by Hongjiang Zhang, Ji Du, Jiannan Lei, Kunhua Wu, Zujun Hou, Lei Lei, Bo Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13350542.txt.
Description
Hongjiang Zhang and co-authors tested in 2026 a distributed-parameter model using quantitative dynamic contrast MRI. It aims to split clinically significant prostate cancer from insignificant disease. This split guides whether to treat or watch. Multiparametric MRI is key for spotting. Yet contrast imaging remains largely qualitative in current reporting rules.
Patients with suspected prostate cancer were enrolled prospectively. Pharmacokinetic maths was applied to contrast uptake curves. Traits that mirror blood flow and permeability were derived. The model was weighed against standard checks. If validated, quantitative contrast work could sharpen biopsy picks. It could cut both missed fierce cancers and overtreatment of indolent ones.
Catalog record
| CREATOR | Hongjiang Zhang, Ji Du, Jiannan Lei, Kunhua Wu, Zujun Hou, Lei Lei, Bo Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |